Annals of Oncology

In this issue:

Ann Oncol 16: 1215; doi:10.1093/annonc/mdi297
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Editorials:

F. J. Lejeune

What is the impact of sentinel node biopsy in the management of cancer?
Annals of Oncology Advance Access published on July 1, 2005
Ann Oncol 16: 1217-1218; doi:10.1093/annonc/mdi298
[Extract] [FREE Full Text] [PDF] [Request Permissions]

M. Colleoni, S. Gelber, and A. Goldhirsch

Treatment of advanced breast cancer: the good, the bad and the ugly
Annals of Oncology Advance Access published on May 13, 2005
Ann Oncol 16: 1219-1221; doi:10.1093/annonc/mdi255
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

E. Terpos and M.-A. Dimopoulos

Myeloma bone disease: pathophysiology and management
Annals of Oncology Advance Access published on May 31, 2005
Ann Oncol 16: 1223-1231; doi:10.1093/annonc/mdi235
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Copie-Bergman, C. Locher, M. Levy, M. T. Chaumette, C. Haioun, M. H. Delfau-Larue, K. Leroy, P. Gaulard, and J. C. Delchier

Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma?
Annals of Oncology Advance Access published on May 12, 2005
Ann Oncol 16: 1232-1236; doi:10.1093/annonc/mdi242
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Gynecologic tumors:

E. Barranger, C. Coutant, A. Cortez, S. Uzan, and E. Darai

Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease
Annals of Oncology Advance Access published on May 12, 2005
Ann Oncol 16: 1237-1242; doi:10.1093/annonc/mdi245
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Breast cancer:

G. Bocci, M. Tuccori, U. Emmenegger, V. Liguori, A. Falcone, R. S. Kerbel, and M. Del Tacca

Cyclophosphamide-methotrexate ‘metronomic’ chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation
Annals of Oncology Advance Access published on May 19, 2005
Ann Oncol 16: 1243-1252; doi:10.1093/annonc/mdi240
[Abstract] [FREE Full Text] [PDF] [Supplementary Data] [Request Permissions]

J. A. Menendez, L. Vellon, and R. Lupu

Antitumoral actions of the anti-obesity drug orlistat (Xenical^TM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene
Annals of Oncology Advance Access published on May 3, 2005
Ann Oncol 16: 1253-1267; doi:10.1093/annonc/mdi239
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Frasci, G. D'Aiuto, P. Comella, R. Thomas, G. Botti, M. Di Bonito, M. D'Aiuto, G. Romano, M. R. Rubulotta, and G. Comella On behalf of the Southern Italy Cooperative Oncology Group (SICOG), Italy

A 2-month cisplatin–epirubicin–paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study
Annals of Oncology Advance Access published on June 3, 2005
Ann Oncol 16: 1268-1275; doi:10.1093/annonc/mdi256
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Brunello, U. Basso, C. Pogliani, A. Jirillo, C. Ghiotto, H. Koussis, F. Lumachi, M. Iacobone, L. Vamvakas, and S. Monfardini

Adjuvant chemotherapy for elderly patients (70 years) with early high-risk breast cancer: a retrospective analysis of 260 patients
Annals of Oncology Advance Access published on May 26, 2005
Ann Oncol 16: 1276-1282; doi:10.1093/annonc/mdi257
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

M. Vanhuyse, C. Fournier, and J. Bonneterre

Chemotherapy-induced amenorrhea: influence on disease-free survival and overall survival in receptor-positive premenopausal early breast cancer patients
Annals of Oncology Advance Access published on May 3, 2005
Ann Oncol 16: 1283-1288; doi:10.1093/annonc/mdi241
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

B. T. Hennessy, A. M. Gauthier, L. B. Michaud, G. Hortobagyi, and V. Valero

Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature
Annals of Oncology Advance Access published on May 12, 2005
Ann Oncol 16: 1289-1296; doi:10.1093/annonc/mdi253
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

W. J. Gradishar, S. B. Wedam, M. Jahanzeb, J. Erban, S. A. Limentani, K.-T. Tsai, S. R. Olsen, and S. M. Swain

Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer
Annals of Oncology Advance Access published on May 19, 2005
Ann Oncol 16: 1297-1304; doi:10.1093/annonc/mdi254
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

F. V. Negri, A. Wotherspoon, D. Cunningham, A. R. Norman, G. Chong, and P. J. Ross

Mucinous histology predicts for reduced fluorouracil responsiveness and survival in advanced colorectal cancer
Annals of Oncology Advance Access published on April 27, 2005
Ann Oncol 16: 1305-1310; doi:10.1093/annonc/mdi244
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

G. Folprecht, A. Grothey, S. Alberts, H.-R. Raab, and C.-H. Köhne

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates
Annals of Oncology Advance Access published on May 3, 2005
Ann Oncol 16: 1311-1319; doi:10.1093/annonc/mdi246
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. M. Mauer, E. H. Kraut, S. A. Krauss, R. H. Ansari, K. Kasza, L. Szeto, and E. E. Vokes for the University of Chicago Phase II Network

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus
Annals of Oncology Advance Access published on May 26, 2005
Ann Oncol 16: 1320-1325; doi:10.1093/annonc/mdi249
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. Kollmannsberger, W. Budach, M. Stahl, N. Schleucher, T. Hehr, H. Wilke, J. Schleicher, U. Vanhoefer, E. C. Jehle, K. Oechsle, T. Trarbach, I. Boehlke, L. Kanz, J. T. Hartmann, and C. Bokemeyer

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO
Annals of Oncology Advance Access published on May 26, 2005
Ann Oncol 16: 1326-1333; doi:10.1093/annonc/mdi252
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

X.-T. Zhang, L.-Y. Li, X.-L. Mu, Q.-C. Cui, X.-Y. Chang, W. Song, S.-L. Wang, M.-Z. Wang, W. Zhong, and L. Zhang

The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on June 14, 2005
Ann Oncol 16: 1334-1342; doi:10.1093/annonc/mdi340
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

M. Campone, H. Roché, P. Kerbrat, J. Bonneterre, P. Romestaing, P. Fargeot, M. Namer, A. Monnier, P. Montcuquet, M.-J. Goudier, and P. Fumoleau On behalf of the FASG (French Adjuvant Study Group), France

Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group
Annals of Oncology Advance Access published on May 19, 2005
Ann Oncol 16: 1343-1351; doi:10.1093/annonc/mdi251
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

S. Monfardini, S. M. L. Aversa, V. Zoli, L. Salvagno, A. Bianco, R. Bordonaro, G. Benevolo, M. Crugnola, G. Crivellari, P. Vivaldi, U. Basso, and V. Torri On behalf of the Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG)

Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
Annals of Oncology Advance Access published on April 27, 2005
Ann Oncol 16: 1352-1358; doi:10.1093/annonc/mdi243
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Josting, M. Sieniawski, J.-P. Glossmann, O. Staak, L. Nogova, N. Peters, M. Mapara, B. Dörken, Y. Ko, B. Metzner, J. Kisro, V. Diehl, and A. Engert

High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study
Annals of Oncology Advance Access published on June 6, 2005
Ann Oncol 16: 1359-1365; doi:10.1093/annonc/mdi248
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C.-C. Chen, C.-F. Yang, M.-H. Yang, K.-D. Lee, W.-K. Kwang, J.-Y. You, Y.-B. Yu, C.-H. Ho, C.-H. Tzeng, W.-K. Chau, H.-C. Hsu, and J.-P. Gau

Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia
Annals of Oncology Advance Access published on June 14, 2005
Ann Oncol 16: 1366-1373; doi:10.1093/annonc/mdi259
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Miscellaneous tumors:

E. Bajetta, L. Catena, G. Procopio, E. Bichisao, L. Ferrari, S. Della Torre, S. De Dosso, S. Iacobelli, R. Buzzoni, L. Mariani, and J. Rosai

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?
Annals of Oncology Advance Access published on June 6, 2005
Ann Oncol 16: 1374-1380; doi:10.1093/annonc/mdi258
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

W. H. Krüger, J. Bohlius, O. A. Cornely, H. Einsele, H. Hebart, G. Massenkeil, S. Schüttrumpf, G. Silling, A. J. Ullmann, D. T. Waldschmidt, and H.-H. Wolf

Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Oncology
Annals of Oncology Advance Access published on May 19, 2005
Ann Oncol 16: 1381-1390; doi:10.1093/annonc/mdi238
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

S. N. Holden, S. G. Eckhardt, R. Basser, R. de Boer, D. Rischin, M. Green, M. A. Rosenthal, C. Wheeler, A. Barge, and H. I. Hurwitz

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors
Annals of Oncology Advance Access published on May 19, 2005
Ann Oncol 16: 1391-1397; doi:10.1093/annonc/mdi247
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

H. Ghesquieres

Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy
Annals of Oncology Advance Access published on April 27, 2005
Ann Oncol 16: 1399; doi:10.1093/annonc/mdi232
[Extract] [FREE Full Text] [PDF] [Request Permissions]

H. Shimada, H. Shima, N. Shimasaki, H. Yoshihara, T. Mori, and T. Takahashi

Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation
Annals of Oncology Advance Access published on April 27, 2005
Ann Oncol 16: 1400; doi:10.1093/annonc/mdi233
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Y. H. Park, S. Kim, S.-J. Choi, B.-Y. Ryoo, S. H. Yang, G. J. Cheon, C.-W. Choi, S. M. Lim, J. Y. Yoo, and S.-S. Lee

Clinical impact of whole-body FDG-PET for evaluation of response and therapeutic decision-making of primary lymphoma of bone
Annals of Oncology Advance Access published on May 3, 2005
Ann Oncol 16: 1401-1402; doi:10.1093/annonc/mdi234
[Extract] [FREE Full Text] [PDF] [Request Permissions]

I. Cohen

Response to "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by L. Morales et al. (Ann Oncol 2005; 16: 70–74)
Annals of Oncology Advance Access published on May 4, 2005
Ann Oncol 16: 1402; doi:10.1093/annonc/mdi236
[Extract] [FREE Full Text] [PDF] [Request Permissions]

R. Paridaens, L. Morales, P. Neven, and D. Timmerman On behalf of all co-authors of the original article

Reply to the Letter to the Editor on "Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients", by I. Cohen Ann Oncol 2005; 16: 1399
Annals of Oncology Advance Access published on May 3, 2005
Ann Oncol 16: 1402-1403; doi:10.1093/annonc/mdi237
[Extract] [FREE Full Text] [PDF] [Request Permissions]

G. Ferretti, M. Mandalà, E. Bria, P. Papaldo, P. Carlini, A. Fabi, M. Milella, E. M. Ruggeri, C. Nisticò, and F. Cognetti

Is cardiac troponin T serum level an accurate surrogate for acute doxorubicin-related myocardial injury?
Annals of Oncology Advance Access published on April 27, 2005
Ann Oncol 16: 1403-1404; doi:10.1093/annonc/mdi203
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.